Analysis of Histologic, Immunohistochemical and Genomic Features of Large B Cell Lymphoma Tumors May Predict Response to Polatuzumab Vedotin Based Therapy in Patients With Relapsed/Refractory Disease
| Autor: | Schneider, Michael, Nasta, Sunita D., Barta, Stefan K., Chong, Elise A., Svoboda, Jakub, Schuster, Stephen J., Landsburg, Daniel J. ⁎ |
|---|---|
| Zdroj: | In Clinical Lymphoma, Myeloma and Leukemia January 2025 25(1):45-51 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect